RESUMO
Plasmodium parasites are exposed to endogenous and exogenous oxidative stress during their complex life cycle. To minimize oxidative damage, the parasites use glutathione (GSH) and thioredoxin (Trx) as primary antioxidants. We previously showed that disruption of the Plasmodium berghei gamma-glutamylcysteine synthetase (pbggcs-ko) or the glutathione reductase (pbgr-ko) genes resulted in a significant reduction of GSH in intraerythrocytic stages, and a defect in growth in the pbggcs-ko parasites. In this report, time course experiments of parasite intraerythrocytic development and morphological studies showed a growth delay during the ring to schizont progression. Morphological analysis shows a significant reduction in size (diameter) of trophozoites and schizonts with increased number of cytoplasmic vacuoles in the pbggcs-ko parasites in comparison to the wild type (WT). Furthermore, the pbggcs-ko mutants exhibited an impaired response to oxidative stress and increased levels of nuclear DNA (nDNA) damage. Reduced GSH levels did not result in mitochondrial DNA (mtDNA) damage or protein carbonylations in neither pbggcs-ko nor pbgr-ko parasites. In addition, the pbggcs-ko mutant parasites showed an increase in mRNA expression of genes involved in oxidative stress detoxification and DNA synthesis, suggesting a potential compensatory mechanism to allow for parasite proliferation. These results reveal that low GSH levels affect parasite development through the impairment of oxidative stress reduction systems and damage to the nDNA. Our studies provide new insights into the role of the GSH antioxidant system in the intraerythrocytic development of Plasmodium parasites, with potential translation into novel pharmacological interventions.
Assuntos
Glutamato-Cisteína Ligase/genética , Glutationa Redutase/genética , Glutationa/metabolismo , Malária/parasitologia , Plasmodium berghei/genética , Animais , Antioxidantes/metabolismo , Núcleo Celular/genética , Dano ao DNA/genética , DNA Mitocondrial/genética , Técnicas de Inativação de Genes , Glutationa/deficiência , Estágios do Ciclo de Vida/genética , Malária/tratamento farmacológico , Malária/genética , Estresse Oxidativo/genética , Plasmodium berghei/crescimento & desenvolvimento , Plasmodium berghei/patogenicidade , Tiorredoxinas/genética , Tiorredoxinas/metabolismoRESUMO
Oxidative stress and mitochondrial dysfunction have been implicated in the pathology of HD; however, the precise mechanisms by which mutant huntingtin modulates levels of oxidative damage in turn resulting in mitochondrial dysfunction are not known. We hypothesize that mutant huntingtin increases oxidative mtDNA damage leading to mitochondrial dysfunction. We measured nuclear and mitochondrial DNA lesions and mitochondrial bioenergetics in the STHdhQ7 and STHdhQ111 in vitro striatal model of HD. Striatal cells expressing mutant huntingtin show higher basal levels of mitochondrial-generated ROS and mtDNA lesions and a lower spare respiratory capacity. Silencing of APE1, the major mammalian apurinic/apyrimidinic (AP) endonuclease that participates in the base excision repair (BER) pathway, caused further reductions of spare respiratory capacity in the mutant huntingtin-expressing cells. Localization experiments show that APE1 increases in the mitochondria of wild-type Q7 cells but not in the mutant huntingtin Q111 cells after treatment with hydrogen peroxide. Moreover, these results are recapitulated in human HD striata and HD skin fibroblasts that show significant mtDNA damage (increased lesion frequency and mtDNA depletion) and significant decreases in spare respiratory capacity, respectively. These data suggest that mtDNA is a major target of mutant huntingtin-associated oxidative stress and may contribute to subsequent mitochondrial dysfunction and that APE1 (and, by extension, BER) is an important target in the maintenance of mitochondrial function in HD.
Assuntos
DNA Mitocondrial/metabolismo , DNA Liase (Sítios Apurínicos ou Apirimidínicos)/metabolismo , Doença de Huntington/metabolismo , Mitocôndrias/metabolismo , Renovação Mitocondrial , Neostriado/metabolismo , Animais , Autopsia , Núcleo Celular/metabolismo , Dano ao DNA , DNA Mitocondrial/efeitos dos fármacos , DNA Liase (Sítios Apurínicos ou Apirimidínicos)/genética , Fibroblastos/metabolismo , Fibroblastos/patologia , Expressão Gênica , Humanos , Proteína Huntingtina , Doença de Huntington/genética , Doença de Huntington/patologia , Peróxido de Hidrogênio/farmacologia , Camundongos , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/genética , Mutação , Neostriado/patologia , Proteínas do Tecido Nervoso/genética , Proteínas do Tecido Nervoso/metabolismo , Oxirredução , Estresse Oxidativo , Cultura Primária de CélulasRESUMO
While the mechanisms of cellular aging remain controversial, a leading hypothesis is that mitochondrial oxidative stress and mitochondrial dysfunction play a critical role in this process. Here, we provide data in aging rhesus macaques supporting the hypothesis that increased oxidative stress is a major characteristic of aging and may be responsible for the age-associated increase in mitochondrial dysfunction. We measured mitochondrial DNA (mtDNA) damage by quantitative PCR in liver and peripheral blood mononuclear cells of young, middle age, and old monkeys and show that older monkeys have increases in the number of mtDNA lesions. There was a direct correlation between the amount of mtDNA lesions and age, supporting the role of mtDNA damage in the process of aging. Liver from older monkeys showed significant increases in lipid peroxidation, protein carbonylations and reduced antioxidant enzyme activity. Similarly, peripheral blood mononuclear cells from the middle age group showed increased levels in carbonylated proteins, indicative of high levels of oxidative stress. Together, these results suggest that the aging process is associated with defective mitochondria, where increased production of reactive oxygen species results in extensive damage at the mtDNA and protein levels. This study provides valuable data based on the rhesus macaque model further validating age-related mitochondrial functional decline with increasing age and suggesting that mtDNA damage might be a good biomarker of aging.
Assuntos
Envelhecimento/fisiologia , Dano ao DNA/fisiologia , DNA Mitocondrial , Mitocôndrias Hepáticas/genética , Estresse Oxidativo/fisiologia , Envelhecimento/metabolismo , Animais , Catalase/metabolismo , Complexo de Proteínas da Cadeia de Transporte de Elétrons/metabolismo , Glutationa Peroxidase/metabolismo , Leucócitos Mononucleares/metabolismo , Peroxidação de Lipídeos/fisiologia , Fígado/anatomia & histologia , Fígado/metabolismo , Macaca mulatta , Masculino , Mitocôndrias Hepáticas/metabolismo , Mitocôndrias Hepáticas/fisiologia , Carbonilação Proteica/fisiologia , Espécies Reativas de Oxigênio/metabolismoRESUMO
Introducción. Se presenta en este artículo los resultados del Programa para Prevención de Retraso Mental por Hipotiroidismo Congénito del Laboratorio Regional del Suereste. El objetivo del estudio fue mostrar la frecuencia de este problema en las muestras enviadas por los hospitales de Yucatán, Campeche, Quintana Roo, Chiapas, Tabasco y Oaxaca; asimismo, se describen algunos problemas y dificultades realcionados con éste. Material y métodos. Se estudiaron 58,154 muestras de sangre de niños en edades comprendidas desde el nacimiento hasta los 3 meses de edad, durante el período de enero de 1993 a diciembre de 1995. Resultados. Se detectó 20 casos de hipotiroidismo congénito, lo cual dio una incidencia de 1 caso en 2,907 recién nacidos tamizados. Conclusión. La incidencia fue menor a la reportada en estudios efectuados en México; asimismo, se identificaron algunos problemas relacionados con la toma de la muestras y los seguimientos de los casos sospechosos